Literature DB >> 25401375

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.

Michael D Miedema1, Faye L Lopez2, Michael J Blaha3, Salim S Virani4, Josef Coresh5, Christie M Ballantyne6, Aaron R Folsom2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25401375      PMCID： PMC4652650          DOI： 10.1001/jamainternmed.2014.6288

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Authors:  Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

3.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

4.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897
  4 in total
  8 in total

1.  Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.

Authors:  Avinainder Singh; Bradley L Collins; Ankur Gupta; Amber Fatima; Arman Qamar; David Biery; Julio Baez; Mary Cawley; Josh Klein; Jon Hainer; Jorge Plutzky; Christopher P Cannon; Khurram Nasir; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2017-11-12       Impact factor: 24.094

2.  Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.

Authors:  Yashashwi Pokharel; Fengming Tang; Philip G Jones; Vijay Nambi; Vera A Bittner; Ravi S Hira; Khurram Nasir; Paul S Chan; Thomas M Maddox; William J Oetgen; Paul A Heidenreich; William B Borden; John A Spertus; Laura A Petersen; Christie M Ballantyne; Salim S Virani
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

Review 3.  Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.

Authors:  Miguel Cainzos-Achirica; Chintan S Desai; Libin Wang; Michael J Blaha; Francisco Lopez-Jimenez; Stephen L Kopecky; Roger S Blumenthal; Seth S Martin
Journal:  Mayo Clin Proc       Date:  2015-08-11       Impact factor: 7.616

Review 4.  Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.

Authors:  Monica Teng; Liang Lin; Ying Jiao Zhao; Ai Leng Khoo; Barry R Davis; Quek Wei Yong; Tiong Cheng Yeo; Boon Peng Lim
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

5.  Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.

Authors:  Michael D Miedema; Ross F Garberich; Lucas J Schnaidt; Erin Peterson; Craig Strauss; Scott Sharkey; Thomas Knickelbine; Marc C Newell; Timothy D Henry
Journal:  J Am Heart Assoc       Date:  2017-04-12       Impact factor: 5.501

6.  Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.

Authors:  Chuannan Zhai; Kai Hou; Rui Li; YueCheng Hu; JingXia Zhang; YingYi Zhang; Le Wang; Rui Zhang; HongLiang Cong
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system.

Authors:  Abbey C Sidebottom; Marc C Vacquier; Joseph C Jensen; Steven M Bradley; Thomas Knickelbine; Craig Strauss; Michael D Miedema
Journal:  Clin Cardiol       Date:  2020-02-27       Impact factor: 2.882

8.  Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Michael D Miedema; Zeina A Dardari; Sina Kianoush; Salim S Virani; Joseph Yeboah; Thomas Knickelbine; Veit Sandfort; Carlos J Rodriguez; Khurram Nasir; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2018-06-13       Impact factor: 5.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.